共 50 条
- [1] Rituximab plus chemotherapy as first-line treatment in Chinese patients with diffuse large B-cell lymphoma in routine practice: a prospective, multicentre, non-interventional studyBMC CANCER, 2016, 16Wu, JianqiuSong, YongpingSu, LipingXu, LiChen, TingchaoZhao, ZhiyunZhang, MingzhiLi, WeiHu, YuZhang, XiaohongGao, YuhuanNiu, ZuoxingFeng, RuWang, WeiPeng, JiewenLi, XiaolinOuyang, XuenongWu, ChangpingZhang, WeijingZeng, YunXiao, ZhenLiang, YingminZhuang, YongzhiWang, JishiSun, ZiminBai, HaiCui, TongjianFeng, Jifeng
- [2] A Prospective, Observational Study on the Safety and Effectiveness of Rituximab Plus Chemotherapy As the First-Line Treatment of Diffuse Large B-Cell LymphomaBLOOD, 2014, 124 (21)Feng, JifengWu, JianqiuSong, YongpingSu, LipingZhang, MingzhiLi, WeiHu, YuZhang, XiaohongGao, YuhuanFeng, RuWang, WeiNiu, ZuoxingPeng, JiewenLi, XiaolinOuyang, XuenongWu, ChangingZhang, WeijingZeng, YunXiao, ZhenLiang, YingminZhuang, YongzhiWang, JishiSun, ZiminBai, HaiCui, Tongjian
- [3] The Role of Transplantation in Diffuse Large B-Cell Lymphoma: The Impact of Rituximab Plus Chemotherapy in First-line and Relapsed SettingsCurrent Hematologic Malignancy Reports, 2011, 6 : 47 - 57Celso Arrais RodriguesPoliana Alves PatahYana A. S. NovisChitra HosingMarcos de Lima
- [4] The Role of Transplantation in Diffuse Large B-Cell Lymphoma: The Impact of Rituximab Plus Chemotherapy in First-line and Relapsed SettingsCURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2011, 6 (01) : 47 - 57Rodrigues, Celso ArraisPatah, Poliana AlvesNovis, Yana A. S.Hosing, Chitrade Lima, Marcos
- [5] Multicentre phase II study of CyclOBEAP plus rituximab in patients with diffuse large B-cell lymphomaHEMATOLOGICAL ONCOLOGY, 2010, 28 (02) : 68 - 74Niitsu, NozomiKohri, MikaHagiwara, YukiTanae, KenTakahashi, NaokiBessho, MasamiOkamoto, Masataka
- [6] Three-Year Follow-up on Safety and Effectiveness of Rituximab Plus Chemotherapy As First-Line Treatment of Diffuse Large B-Cell LymphomaBLOOD, 2017, 130Feng, JifengWu, JianqiuSong, YongpingSu, LipingZhang, MingzhiLi, WeiHu, YuZhang, XiaohongGao, YuhuanNiu, ZuoxingFeng, RuWang, WeiPeng, JiewenLi, XiaolinOuyang, XuenongWu, ChangpingZhang, WeijingZeng, YunXiao, ZhenLiang, YingminZhuang, YongzhiWang, JishiSun, ZiminBai, HaiCui, Tongjian
- [7] Comparative Effectiveness and Cost of Adding Rituximab to First-Line Chemotherapy for Elderly Patients Diagnosed With Diffuse Large B-Cell LymphomaCANCER, 2012, 118 (24) : 6079 - 6088Griffiths, Robert I.Gleeson, Michelle L.Mikhael, JosephDreyling, Martin H.Danese, Mark D.
- [8] Diffuse large-cell B-cell lymphoma: first-line treatment without chemotherapy in frail elderly patients lenalidomide-rituximab combinationHEMATOLOGIE, 2023, 29 (06): : 330 - 332Houtteghem, Tristan Robert-Van
- [9] Subcutaneous rituximab in patients with diffuse large B cell lymphoma and follicular lymphoma: Final results of the non-interventional study MabSCaleCANCER MEDICINE, 2023, 12 (03): : 2739 - 2751Duerig, JanUhlig, JensGerhardt, AnkeRitter, MarkusHapke, GunnarHessling, JoergStaib, PeterWolff, FriederKrumm, Katjavon Weikersthal, Ludwig Fischer
- [10] A phase 2 study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse large B-cell lymphomaBLOOD, 2021, 137 (05) : 600 - 609Morschhauser, FranckFeugier, PierreFlinn, Ian W.Gasiorowski, RobinGreil, RichardIlles, ArpadJohnson, Nathalie A.Larouche, Jean-FrancoisLugtenburg, Pieternella J.Patti, CaterinaSalles, Gilles AndreTrneny, Marekde Vos, SvenMir, FarheenSamineni, DivyaKim, Su Y.Jiang, YanwenPunnoose, ElizabethSinha, ArijitClark, EmmaSpielewoy, NathalieHumphrey, KathrynBazeos, AlexandraZelenetz, Andrew D.